91 related articles for article (PubMed ID: 9291574)
1. Synthesis of 6'-GM2, a regioisomer of ganglioside GM2, for studying the mechanism of action of GM2 activator.
Ishida H; Ito Y; Tanahashi E; Li YT; Kiso M; Hasegawa A
Carbohydr Res; 1997 Aug; 302(3-4):223-7. PubMed ID: 9291574
[No Abstract] [Full Text] [Related]
2. Design and efficient synthesis of novel GM2 analogues with respect to the elucidation of the function of GM2 activator.
Komori T; Ando T; Imamura A; Li YT; Ishida H; Kiso M
Glycoconj J; 2008 Oct; 25(7):647-61. PubMed ID: 18368480
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for the enzymatic resistance of the GM2 ganglioside.
Li YT; Li SC; Ishida H; Kiso M; Raimondi L; Bernardi A; Sonnino S
Methods Enzymol; 2003; 363():242-64. PubMed ID: 14579580
[No Abstract] [Full Text] [Related]
4. Chemical Synthesis of GM2 Glycans, Bioconjugation with Bacteriophage Qβ, and the Induction of Anticancer Antibodies.
Yin Z; Dulaney S; McKay CS; Baniel C; Kaczanowska K; Ramadan S; Finn MG; Huang X
Chembiochem; 2016 Jan; 17(2):174-80. PubMed ID: 26538065
[TBL] [Abstract][Full Text] [Related]
5. GM2 ganglioside activator occurs in multiple forms.
Novak A; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):209-14. PubMed ID: 8123670
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and enzymatic susceptibility of a series of novel GM2 analogs.
Fuse T; Ando H; Imamura A; Sawada N; Ishida H; Kiso M; Ando T; Li SC; Li YT
Glycoconj J; 2006 Jul; 23(5-6):329-43. PubMed ID: 16897176
[TBL] [Abstract][Full Text] [Related]
7. Total synthesis of a modified ganglioside, de-N-acetyl GM2.
Fujita S; Numata M; Sugimoto M; Tomita K; Ogawa T
Carbohydr Res; 1994 Oct; 263(2):181-96. PubMed ID: 7805050
[TBL] [Abstract][Full Text] [Related]
8. Induction of a melanoma-specific antibody response by a monovalent, but not a divalent, synthetic GM2 neoglycopeptide.
Bay S; Fort S; Birikaki L; Ganneau C; Samain E; Coïc YM; Bonhomme F; Dériaud E; Leclerc C; Lo-Man R
ChemMedChem; 2009 Apr; 4(4):582-7. PubMed ID: 19226501
[TBL] [Abstract][Full Text] [Related]
9. Total synthesis of gangliosides GM1 and GM2.
Sugimoto M; Numata M; Koike K; Nakahara Y; Ogawa T
Carbohydr Res; 1986 Nov; 156():C1-5. PubMed ID: 3815403
[No Abstract] [Full Text] [Related]
10. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
Schwarzmann G; Wendeler M; Sandhoff K
Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome.
Andersen SM; Ling CC; Zhang P; Townson K; Willison HJ; Bundle DR
Org Biomol Chem; 2004 Apr; 2(8):1199-212. PubMed ID: 15064799
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characterization of the Cys138Arg substitution associated with the AB variant form of GM2 gangliosidosis: evidence that Cys138 is required for the recognition of the GM2 activator/GM2 ganglioside complex by beta-hexosaminidase A.
Xie B; Rigat B; Smiljanic-Georgijev N; Deng H; Mahuran D
Biochemistry; 1998 Jan; 37(3):814-21. PubMed ID: 9454570
[TBL] [Abstract][Full Text] [Related]
13. Induction of antibodies reactive with GM2 ganglioside after immunization with lipopolysaccharides from Camplyobacter jejuni.
Ritter G; Fortunato SR; Cohen L; Noguchi Y; Bernard EM; Stockert E; Old LJ
Int J Cancer; 1996 Apr; 66(2):184-90. PubMed ID: 8603809
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labelling of the human GM2-activator protein. Mechanistic insight into ganglioside GM2 degradation.
Wendeler M; Hoernschemeyer J; Hoffmann D; Kolter T; Schwarzmann G; Sandhoff K
Eur J Biochem; 2004 Feb; 271(3):614-27. PubMed ID: 14728689
[TBL] [Abstract][Full Text] [Related]
15. Precursor-product relationship between GM1 and GD1a biosynthesized from exogenous GM2 ganglioside in rat liver.
Trinchera M; Ghidoni R
J Biochem; 1990 Apr; 107(4):619-23. PubMed ID: 2358435
[TBL] [Abstract][Full Text] [Related]
16. Classification of disorders of GM2 ganglioside hydrolysis using 3H-GM2 as substrate.
Novak A; Callahan JW; Lowden JA
Biochim Biophys Acta; 1994 Mar; 1199(2):215-23. PubMed ID: 8123671
[TBL] [Abstract][Full Text] [Related]
17. Formation of a ternary complex between GM2 activator protein, GM2 ganglioside and hexosaminidase A.
Yadao F; Hechtman P; Kaplan F
Biochim Biophys Acta; 1997 Jun; 1340(1):45-52. PubMed ID: 9217013
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of a functionally active human GM2-activator protein in Escherichia coli.
Klima H; Klein A; van Echten G; Schwarzmann G; Suzuki K; Sandhoff K
Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):571-6. PubMed ID: 8503891
[TBL] [Abstract][Full Text] [Related]
19. Chemoenzymatic synthesis of GM3 and GM2 gangliosides containing a truncated ceramide functionalized for glycoconjugate synthesis and solid phase applications.
Jacques S; Rich JR; Ling CC; Bundle DR
Org Biomol Chem; 2006 Jan; 4(1):142-54. PubMed ID: 16358009
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside GM2 levels in human melanoma cells: inverse correlation with lysosomal beta-hexosaminidase A activity.
Hoon DS; Kaback MM; Lim-Steele J; Tsuchida T; Morton DL; Irie RF
Biochem Int; 1992 Jul; 27(2):343-52. PubMed ID: 1386984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
